drugset / Trial / NCT02033356

ED95 of Lidocaine 1.0% for Filling the Adductor Canal

NCT02033356

Phase 2 Completed 40 enrolled Rigshospitalet, Denmark
Non-randomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this prospective dose finding study is to estimate the minimal effective volume (ED95) for lidocaine 1.0% for filling the adductor canal when placing an adductor canal block. We will apply the Continual Reassessment Method (CRM) for estimating the ED95 and use an MRI scan to evaluate the main objective and ensure spread to the distal part of the adductor canal.

Timeline

Start
2014-01
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 ml Other
Subject Lidocaine Other / unclassified 10 ml Other
Subject Lidocaine Other / unclassified 15 ml Other
Subject Lidocaine Other / unclassified 20 ml Other
Subject Lidocaine Other / unclassified 25 ml Other
Subject Lidocaine Other / unclassified 30 ml Other

Indications

No indication recorded.